Related Experiment Video
Updated: May 17, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae
Roberta Prinapori1, Julie Guinaud, Antoine Khalil
1Infectious Disease Department, Necker-Enfants-Malades Hospital, AP-HP, Université Paris-Descartes, Paris, France.
Abstract:
We evaluated 74 children with previous fecal extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae colonization who were hospitalized and receiving a course of antibiotic therapy for suspected infection. Sixty-four patients (86.5%) received a carbapenem agent. Only 3 patients were infected with an ESBL-producing Enterobacteriaceae. Sixty-one (95%) initial antibiotic courses were considered excessive and required deescalation; however, deescalation was accomplished in only 38 patients (62%). This suggests the need for an ESBL control program to decrease carbapenem use and thereby limit carbapenem resistance in gram-negative bacilli.
Insights
Hospitalized children with previous ESBL colonization often received excessive carbapenem antibiotics. Most antibiotic courses required deescalation, highlighting the need for programs to reduce carbapenem use and combat resistance.
Area of Science:
- Infectious Diseases
- Microbiology
- Pediatrics
Background:
- Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae colonization is a growing concern in pediatric populations.
- Hospitalized children with suspected infections often receive broad-spectrum antibiotics, including carbapenems.
Purpose of the Study:
- To evaluate antibiotic prescribing patterns in hospitalized children with prior ESBL colonization.
- To assess the appropriateness of carbapenem use and the feasibility of deescalation in this patient group.
Main Methods:
- Retrospective evaluation of 74 hospitalized children with previous fecal ESBL colonization.
- Analysis of antibiotic therapy, focusing on carbapenem use and subsequent deescalation rates.
Main Results:
- 86.5% of patients received carbapenem agents, despite only 3 patients (4%) being infected with ESBL-producing Enterobacteriaceae.
- 95% of initial antibiotic courses were deemed excessive and candidates for deescalation.
- Successful deescalation was achieved in only 62% of appropriate cases.
Conclusions:
- Carbapenem use is frequently excessive in hospitalized children with prior ESBL colonization.
- Deescalation of antibiotic therapy is challenging, indicating a need for improved stewardship.
- Implementing ESBL control programs can reduce carbapenem use and mitigate the rise of gram-negative bacilli resistance.
Related Concept Videos
Bacterial Gastroenteritis
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Antibiotic Selection

